Your browser doesn't support javascript.
loading
Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars.
Stebbing, Justin; Mainwaring, Paul N; Curigliano, Giuseppe; Pegram, Mark; Latymer, Mark; Bair, Angel H; Rugo, Hope S.
Afiliação
  • Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Mainwaring PN; Center for Personalised Nanomedicine, University of Queensland, Brisbane, Queensland, Australia.
  • Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy.
  • Pegram M; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Latymer M; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA.
  • Bair AH; Pfizer, Sandwich, United Kingdom.
  • Rugo HS; Pfizer, New York, NY.
J Clin Oncol ; 38(10): 1070-1080, 2020 04 01.
Article em En | MEDLINE | ID: mdl-32058846
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Medicamentos Biossimilares / Neoplasias Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Medicamentos Biossimilares / Neoplasias Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article